United States - English - NLM (National Library of Medicine)

eugia us llc - ropivacaine hydrochloride (unii: v910p86109) (ropivacaine - unii:7io5lya57n) - ropivacaine hydrochloride 2 mg in 1 ml - ropivacaine hydrochloride injection is indicated for the production of local or regional anesthesia for surgery and for acute pain management. surgical anesthesia : epidural block for surgery including cesarean section; major nerve block; local infiltration acute pain management : epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration ropivacaine hydrochloride is contraindicated in patients with a known hypersensitivity to ropivacaine or to any local anesthetic agent of the amide type. risk summary there are no available human data on use of ropivacaine hydrochloride injection in pregnant women to evaluate a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. local anesthetics may cause varying degrees of toxicity to the mother and fetus and adverse reactions include alterations of the central nervous system, peripheral vascular tone, and cardiac function (see clinical considerations) . no teratogenicity was obs

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - ropivacaine hydrochloride, quantity: 2 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - post operative analgesia

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - ropivacaine hydrochloride, quantity: 2 mg/ml; fentanyl citrate, quantity: 6.28 microgram/ml (equivalent: fentanyl, qty 4 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - for the management of post-operative pain by epidural infusion for up to 72 hours.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - ropivacaine hydrochloride, quantity: 2 mg/ml; fentanyl citrate, quantity: 3.14 microgram/ml (equivalent: fentanyl, qty 2 microgram/ml) - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium chloride; sodium hydroxide - for the management of post-operative pain by epidural infusion for up to 72 hours.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - ropivacaine hydrochloride - solution for injection - ropivacaine hydrochloride 10 mg/ml - ropivacaine - ropivacaine b. braun 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for:surgical anaesthesialumbar epidural administration for surgery

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - ropivacaine hydrochloride - solution for injection - ropivacaine hydrochloride 2 mg/ml - ropivacaine - ropivacaine b. braun 2mg/ml is indicated for:acute pain management:in adults and adolescents above 12 years of age for:• continuous epidural infusion or intermittent bolus administration during postoperative or labour pain.• field blocks.• peripheral nerve block via continuous infusion or intermittent bolus injections, e.g. postoperative pain management.

Israel - English - Ministry of Health

bioavenir ltd, israel - ropivacaine hydrochloride - solution for injection - ropivacaine hydrochloride 10 mg/ml - ropivacaine - ropivacaine 10 mg/ml is indicated in adults and adolescents above 12 years of age for:surgical anaesthesia: - lumbar epidural administration for surgery

Israel - English - Ministry of Health

bioavenir ltd, israel - ropivacaine hydrochloride - solution for injection - ropivacaine hydrochloride 10 mg/ml - ropivacaine - ropivacaine 10 mg/ml is indicated in adults and adolescents above 12 years of age for:surgical anaesthesia: - lumbar epidural administration for surgery

Israel - English - Ministry of Health

propharm ltd - ropivacaine hydrochloride - solution for injection - ropivacaine hydrochloride 10 mg / 1 ml - ropivacaine - ropivacaine 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for:surgical anaesthesia: lumbar epidural administration for surgery

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ropivacaine 8.826 mg/ml equivalent to ropivacaine hydrochloride 9.971 mg/ml; ropivacaine 8.826 mg/ml equivalent to ropivacaine hydrochloride 10.0 mg/ml - solution for injection - 10 mg/ml - active: ropivacaine 8.826 mg/ml equivalent to ropivacaine hydrochloride 9.971 mg/ml excipient: hydrochloric acid potassium hydroxide sodium chloride water for injection active: ropivacaine 8.826 mg/ml equivalent to ropivacaine hydrochloride 10.0 mg/ml excipient: hydrochloric acid potassium hydroxide sodium chloride water for injection - ropivacaine-aft is indicated for surgical anaesthesia in adults and children over 12 years of age: · epidural block for surgery including caesarean section · intrathecal anaesthesia · field block (minor nerve block and infiltration · major nerve block